NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...

After BioNTech’s acquisition of CureVac closes, BioNTech will pay GSK another $130 million and a 1% royalty on rest-of-world ...

The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian ...

Trump administration has unwisely cancelled mRNA vaccine research while doing little about Americans’ unhealthy diet.

Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...

Market to Reach $430 Million by 2032, Driven by Breakthrough Clinical Trials and Expanding Indications. The global RNA-Based Therape ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...

New messenger RNA vaccines to fight the coronavirus are based on a technology that could transform medicine. Next up: sickle cell and HIV. On December 23, as part of a publicity push to encourage ...